We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-0.51%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$61.6B
AUM Growth
+$1.91B
(+3.2%)
Cap. Flow
+$2.64B
Cap. Flow
% of AUM
4.28%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
769
New
56
Increased
370
Reduced
204
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$259M |
| 2 |
Liberty Media Series C
FWONK
|
+$253M |
| 3 |
Oracle
ORCL
|
+$232M |
| 4 |
Avery Dennison
AVY
|
+$230M |
| 5 |
Emerson Electric
EMR
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$236M |
| 2 |
Liberty Media Series A
FWONA
|
+$224M |
| 3 |
State Street
STT
|
+$220M |
| 4 |
Parker-Hannifin
PH
|
+$185M |
| 5 |
Lear
LEA
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.21% |
| 2 | Technology | 15.31% |
| 3 | Healthcare | 14.81% |
| 4 | Energy | 10.39% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HI
301
DELISTED
Hillenbrand
HI
| $17.7M | 0.03% |
572,725
+15,909
| +3% | +$508K |
|
|
ACH
302
Accendra Health
ACH
$240M
| $17.5M | 0.03% |
534,079
+21,722
| +4% | +$739K |
|
303
Cabot Corp
CBT
$4.65B
| $17.5M | 0.03% |
343,866
+10,490
| +3% | +$576K |
|
304
Granite Construction
GVA
$5.45B
| $17.4M | 0.03% |
545,763
+15,398
| +3% | +$531K |
|
305
Brink's
BCO
$5.02B
| $17.3M | 0.03% |
718,444
+30,576
| +4% | +$819K |
|
306
LSB Industries
LXU
$881M
| $17.2M | 0.03% |
626,401
-38,509
| -6% | -$1.15M |
|
307
Scorpio Tankers
STNG
$3.96B
| $17.2M | 0.03% |
206,667
+10,743
| +5% | +$1.02M |
|
308
Matthews International
MATW
$864M
| $17.1M | 0.03% |
390,158
+5,270
| +1% | +$235K |
|
309
Universal Corp
UVV
$1.34B
| $17M | 0.03% |
383,315
-96,119
| -20% | -$4.96M |
|
|
CELG
310
DELISTED
Celgene Corp
CELG
| $17M | 0.03% |
179,394
-63,851
| -26% | -$5.76M |
|
311
Brady Corp
BRC
$4.45B
| $16.9M | 0.03% |
755,001
+342,777
| +83% | +$8.99M |
|
|
OUTR
312
DELISTED
OUTERWALL INC
OUTR
| $16.7M | 0.03% |
297,081
+231,641
| +354% | +$13.4M |
|
313
Itaú Unibanco
ITUB
$91.3B
| $16.6M | 0.03% |
2,991,363
-12,125
| -0.4% | -$77.3K |
|
|
ISCA
314
DELISTED
International Speedway Corp
ISCA
| $16.1M | 0.03% |
507,843
+24,757
| +5% | +$797K |
|
|
RCAP
315
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
| $16.1M | 0.03% |
713,047
+15,501
| +2% | +$342K |
|
|
PACD
316
DELISTED
Pacific Drilling S A
PACD
| $16M | 0.03% |
193,619
+52,766
| +37% | +$5.08M |
|
317
Stryker
SYK
$127B
| $16M | 0.03% |
198,023
| – | – |
|
|
RSTI
318
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $15.7M | 0.03% |
679,328
+460,015
| +210% | +$10.6M |
|
319
Maximus
MMS
$3.14B
| $15.7M | 0.03% |
390,244
-145,265
| -27% | -$6.01M |
|
320
First Citizens BancShares
FCNCA
$24.6B
| $15.6M | 0.03% |
71,855
+2,410
| +3% | +$544K |
|
321
Halliburton
HAL
$27.9B
| $15.4M | 0.03% |
239,387
-207,515
| -46% | -$14.2M |
|
|
BMCH
322
DELISTED
BMC Stock Holdings, Inc
BMCH
| $15.4M | 0.03% |
982,472
+30,518
| +3% | +$506K |
|
|
CTXS
323
DELISTED
Citrix Systems Inc
CTXS
| $15.4M | 0.02% |
270,575
+12,684
| +5% | +$690K |
|
324
Columbia Banking Systems
COLB
$8.81B
| $15.2M | 0.02% |
612,867
+25,835
| +4% | +$667K |
|
|
WAC
325
DELISTED
Walter Investment Mgt Corp
WAC
| $15.1M | 0.02% |
689,743
-96,498
| -12% | -$2.52M |
|
Similar funds
Boston Partners's Q3 2014 Portfolio in Review
As of Q3 2014, Boston Partners held 769 positions worth $61.6B, up 3.2% from $59.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Boston Partners deployed $2.64B of net new capital in Q3 2014, opening 56 new positions and adding to 370 existing holdings. Its largest new stake was Liberty Media Series C: 9,903,335 shares worth $249M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was ROCK-TENN COMPANY CL-A, an estimated $236M trimmed.
- Boston Partners's largest Q3 2014 buy was Liberty Media Series C: 9,903,335 shares worth $249M.
- Boston Partners added most to Teva Pharmaceuticals in Q3 2014, an estimated $259M increase.
- Boston Partners's biggest Q3 2014 reduction was ROCK-TENN COMPANY CL-A, cutting an estimated $236M.
- Boston Partners fully exited Cigna in Q3 2014, selling an estimated $133M.
- Boston Partners's ten largest holdings make up 19% of its $61.6B portfolio in Q3 2014.
- Boston Partners opened 56 new positions and closed 51 in Q3 2014.
- Boston Partners's portfolio value rose 3.2% quarter-over-quarter to $61.6B.
Based on Boston Partners's 13F filing for Q3 2014, filed 12 Nov 2014.